Exact Mass: 440.2059598
Exact Mass Matches: 440.2059598
Found 240 metabolites which its exact mass value is equals to given mass value 440.2059598
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
3'-Hydroxy-HT2 toxin
3-Hydroxy-HT2 toxin is a mycotoxin from Fusarium heterosporu Mycotoxin from Fusarium heterosporum
Ceranapril
C21H33N2O6P (440.20761280000005)
D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D000806 - Angiotensin-Converting Enzyme Inhibitors D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents
Ibrutinib
C25H24N6O2 (440.19606439999995)
(5E,7R,8R,14Z)-7-Acetoxy-10-chloro-12-hydroxy-9-oxoprosta-5,10,14-triene-1-oic acid methyl ester
C23H33ClO6 (440.19655480000006)
2,4-bis[(4-hydroxyphenyl)methyl]-5-methoxy-3-(2-phenylethyl)phenol
(3alpha,4beta,8alpha)-4-(acetyloxy)-3-(2,3-dihydroxy-2-methyl-1-oxobutoxy)-8-hydroxyeudesm-7(11)-eno-12,8-lactone|rel-(4aR,5S,6R,8aR,9aS)-5-(acetyloxy)-9a-hydroxy-3,5,8a-trimethyl-2-oxo-2,4,4a,5,6,7,8,8a,9,9a-decahydronaphtho[2,3-b]furan-6-yl 2,3-dihydroxy-2-methylbutanoate
6-Deoxy-2-O-alpha-L-rhamnopyranosyl-L-talose-Benzyl glycoside, 3,4-O-isopropylidene
Ala His Val Asp
His Ala Val Asp
Ala Asp His Val
Ala Asp Val His
Ala Phe Phe Gly
Ala Phe Gly Phe
Ala Gly Phe Phe
Ala His Asp Val
Ala Val Asp His
Ala Val His Asp
Asp Ala His Val
Asp Ala Val His
Asp Gly His Ile
Asp Gly His Leu
Asp Gly Ile His
Asp Gly Leu His
Asp His Ala Val
Asp His Gly Ile
Asp His Gly Leu
Asp His Ile Gly
Asp His Leu Gly
Asp His Val Ala
Asp Ile Gly His
Asp Ile His Gly
Asp Leu Gly His
Asp Leu His Gly
Asp Val Ala His
Asp Val His Ala
Glu Gly His Val
Glu Gly Val His
Glu His Gly Val
Glu His Val Gly
Glu Val Gly His
Glu Val His Gly
Phe Ala Phe Gly
Phe Ala Gly Phe
Phe Phe Ala Gly
Phe Phe Gly Ala
Phe Gly Ala Phe
Phe Gly Phe Ala
Gly Ala Phe Phe
Gly Asp His Ile
Gly Asp His Leu
Gly Asp Ile His
Gly Asp Leu His
Gly Glu His Val
Gly Glu Val His
Gly Phe Ala Phe
Gly Phe Phe Ala
Gly His Asp Ile
Gly His Asp Leu
Gly His Glu Val
Gly His Ile Asp
Gly His Leu Asp
Gly His Val Glu
Gly Ile Asp His
Gly Ile His Asp
Gly Leu Asp His
Gly Leu His Asp
Gly Val Glu His
Gly Val His Glu
His Ala Asp Val
His Asp Ala Val
His Asp Gly Ile
His Asp Gly Leu
His Asp Ile Gly
His Asp Leu Gly
His Asp Val Ala
His Glu Gly Val
His Glu Val Gly
His Gly Asp Ile
His Gly Asp Leu
His Gly Glu Val
His Gly Ile Asp
His Gly Leu Asp
His Gly Val Glu
His Ile Asp Gly
His Ile Gly Asp
His Leu Asp Gly
His Leu Gly Asp
His Pro Ser Thr
His Pro Thr Ser
His Ser Pro Thr
His Ser Thr Pro
His Thr Pro Ser
His Thr Ser Pro
His Val Ala Asp
His Val Asp Ala
His Val Glu Gly
His Val Gly Glu
Ile Asp Gly His
Ile Asp His Gly
Ile Gly Asp His
Ile Gly His Asp
Ile His Asp Gly
Ile His Gly Asp
Leu Asp Gly His
Leu Asp His Gly
Leu Gly Asp His
Leu Gly His Asp
Leu His Asp Gly
Leu His Gly Asp
Met Pro Pro Pro
Asn Asn Pro Pro
Asn Pro Asn Pro
Asn Pro Pro Asn
Pro His Ser Thr
Pro His Thr Ser
Pro Met Pro Pro
Pro Asn Asn Pro
Pro Asn Pro Asn
Pro Pro Met Pro
Pro Pro Asn Asn
Pro Pro Pro Met
Pro Ser His Thr
Pro Ser Thr His
Pro Thr His Ser
Pro Thr Ser His
Ser His Pro Thr
Ser His Thr Pro
Ser Pro His Thr
Ser Pro Thr His
Ser Thr His Pro
Ser Thr Pro His
Thr His Pro Ser
Thr His Ser Pro
Thr Pro His Ser
Thr Pro Ser His
Thr Ser His Pro
Thr Ser Pro His
Val Ala Asp His
Val Ala His Asp
Val Asp Ala His
Val Asp His Ala
Val Glu Gly His
Val Glu His Gly
Val Gly Glu His
Val Gly His Glu
Val His Ala Asp
Val His Asp Ala
Val His Glu Gly
Val His Gly Glu
punaglandin 8
C23H33ClO6 (440.19655480000006)
TC3 Toxin
7-Acetoxy-7,8-dihydrochlorovulone II
C23H33ClO6 (440.19655480000006)
Ibrutinib
C25H24N6O2 (440.19606439999995)
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EL - Brutons tyrosine kinase (btk) inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163774 - BTK-targeting Agent COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Ceronapril
C21H33N2O6P (440.20761280000005)
D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D000806 - Angiotensin-Converting Enzyme Inhibitors C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C247 - ACE Inhibitor D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents
Benzyl 7-(diphenylmethyl)-6-oxo-1,7-diazaspiro[4.4]nonane-1-carbo xylate
C28H28N2O3 (440.20998180000004)
3,5-BIS[2-(BOC-AMINO)ETHOXY]-BENZOIC ACID
C21H32N2O8 (440.21585519999996)
5-[2-(3,4-dihydro-2H-quinolin-1-yl)-2-oxoethoxy]-2-[(3-methylphenyl)methyl]-3,4-dihydroisoquinolin-1-one
C28H28N2O3 (440.20998180000004)
Ala-Val-Asp-His
A tetrapeptide composed of L-alanine, L-valine, L-aspartic acid, and L-histidine joined in sequence by peptide linkages.
methyl (1R,9S,10S,11S)-12-(cyclopentylmethyl)-5-(2-fluorophenyl)-10-(hydroxymethyl)-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxylate
(1S,9R,10R,11R)-12-(cyclohexylmethyl)-5-(4-fluorophenyl)-10-(hydroxymethyl)-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxylic acid
(1R,9S,10S,11S)-12-(cyclohexylmethyl)-5-(4-fluorophenyl)-10-(hydroxymethyl)-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxylic acid
methyl (1S,9R,10R,11R)-12-(cyclopentylmethyl)-5-(2-fluorophenyl)-10-(hydroxymethyl)-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxylate
(3s)-3-{[(2s)-2-{[(2s)-2-amino-1-hydroxypropylidene]amino}-1-hydroxy-3-methylbutylidene]amino}-3-{[(1s)-1-carboxy-2-(3h-imidazol-4-yl)ethyl]-c-hydroxycarbonimidoyl}propanoic acid
(2e,4e,6e)-8-({2-[(2,3-dihydroxy-3-methylbutanoyl)oxy]-3-methylpentanoyl}oxy)-8-(2-methyloxiran-2-yl)octa-2,4,6-trienoic acid
(1s,2r,3r,4s,5r,6s)-2,3,6-trihydroxy-4,5-bis[(2-methylbut-2-enoyl)oxy]cyclohexyl (2e)-3-methylpent-2-enoate
methyl (5e,7s)-7-(acetyloxy)-7-[(1r,2s)-4-chloro-2-hydroxy-2-[(2z)-oct-2-en-1-yl]-5-oxocyclopent-3-en-1-yl]hept-5-enoate
C23H33ClO6 (440.19655480000006)
(2s,3s,5r,6s)-3-{[(3s)-3-amino-1-hydroxy-5-(n-methylcarbamimidamido)pentylidene]amino}-5-hydroxy-6-(2-hydroxy-4-iminopyrimidin-1-yl)oxane-2-carboxylic acid
methyl 7-(acetyloxy)-7-[4-chloro-2-hydroxy-2-(oct-2-en-1-yl)-5-oxocyclopent-3-en-1-yl]hept-5-enoate
C23H33ClO6 (440.19655480000006)
(1s,2r,3s,5r,6r,8r,9r,10r,11s)-9-(acetyloxy)-2,6-dihydroxy-3,8-dimethyl-12-methylidene-13-oxo-4,14-dioxatricyclo[9.3.0.0³,⁵]tetradecan-10-yl (2s)-2-methylbutanoate
4-[(acetyloxy)methyl]-7-hydroxy-7-(hydroxymethyl)-1-[(3-methylbutanoyl)oxy]-1h,6h,7ah-cyclopenta[c]pyran-6-yl 3-methylbutanoate
(1r,2s,3r,5r,6s,8s,9r,10s,11r)-9-(acetyloxy)-2,6-dihydroxy-3,8-dimethyl-12-methylidene-13-oxo-4,14-dioxatricyclo[9.3.0.0³,⁵]tetradecan-10-yl (2r)-2-methylbutanoate
9-(acetyloxy)-2,6-dihydroxy-3,8-dimethyl-12-methylidene-13-oxo-4,14-dioxatricyclo[9.3.0.0³,⁵]tetradecan-10-yl 2-methylbutanoate
(1s,4ar,6s,7r,7as)-6-(acetyloxy)-4a-hydroxy-1-[(3-methylbutanoyl)oxy]-1,5,6,7a-tetrahydrospiro[cyclopenta[c]pyran-7,2'-oxiran]-4-ylmethyl 3-methylbutanoate
(1s,6s,7r,7as)-4-[(acetyloxy)methyl]-7-hydroxy-7-(hydroxymethyl)-1-[(3-methylbutanoyl)oxy]-1h,6h,7ah-cyclopenta[c]pyran-6-yl 3-methylbutanoate
4-[2-(3-hydroxyphenyl)ethyl]-2-{4-[2-(3-methoxyphenyl)ethyl]phenoxy}phenol
2-{4-[2-(3-hydroxyphenyl)ethyl]phenoxy}-4-[2-(3-methoxyphenyl)ethyl]phenol
{4-[(acetyloxy)methyl]-6,7-dihydroxy-1-[(3-methylbutanoyl)oxy]-1h,6h,7ah-cyclopenta[c]pyran-7-yl}methyl 3-methylbutanoate
6-(acetyloxy)-4a-hydroxy-1-[(3-methylbutanoyl)oxy]-1,5,6,7a-tetrahydrospiro[cyclopenta[c]pyran-7,2'-oxiran]-4-ylmethyl 3-methylbutanoate
(1s,2r,3r,4s,5r,6s)-2,3,6-trihydroxy-4,5-bis({[(2z)-2-methylbut-2-enoyl]oxy})cyclohexyl (2e)-3-methylpent-2-enoate
3-chloro-5-[(2e,6e,10s)-10,11-dihydroxy-3,7,11-trimethyldodeca-2,6-dien-1-yl]-4,6-dihydroxy-2-methylbenzoic acid
C23H33ClO6 (440.19655480000006)